123 related articles for article (PubMed ID: 20807368)
1. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes.
Ying AK; Lairson DR; Giardino AP; Bondy ML; Zaheer I; Haymond MW; Heptulla RA
Pediatr Diabetes; 2011 May; 12(3 Pt 1):177-82. PubMed ID: 20807368
[TBL] [Abstract][Full Text] [Related]
2. Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
Bächle CC; Holl RW; Straßburger K; Molz E; Chernyak N; Beyer P; Schimmel U; Rütschle H; Seidel J; Lepler R; Holder M; Rosenbauer J; Icks A; ;
Diabet Med; 2012 Oct; 29(10):1327-34. PubMed ID: 22417295
[TBL] [Abstract][Full Text] [Related]
3. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
4. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
5. Technology and the issue of cost/benefit in diabetes.
Giannini C; Mohn A; Chiarelli F
Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
[TBL] [Abstract][Full Text] [Related]
6. Costs of managing severe hypoglycaemia in three European countries.
Hammer M; Lammert M; Mejías SM; Kern W; Frier BM
J Med Econ; 2009; 12(4):281-90. PubMed ID: 20001570
[TBL] [Abstract][Full Text] [Related]
7. The persistent complication of hypoglycemia in diabetics.
Dangi-Garimella S
Am J Manag Care; 2014 May; 20(8 Spec No.):E17. PubMed ID: 25617934
[No Abstract] [Full Text] [Related]
8. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
9. The economic effect of hypoglycemia in a health plan.
Heaton A; Martin S; Brelje T
Manag Care Interface; 2003 Jul; 16(7):23-7. PubMed ID: 12908214
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and costs of diabetes treated with insulin in France.
Detournay B; Raccah D; Cadilhac M; Eschwège E
Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
[TBL] [Abstract][Full Text] [Related]
11. Economic cost associated with type II diabetes in Spanish patients.
Ballesta M; Carral F; Olveira G; Girón JA; Aguilar M
Eur J Health Econ; 2006 Dec; 7(4):270-5. PubMed ID: 16850331
[TBL] [Abstract][Full Text] [Related]
12. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.
Johnson JA; Pohar SL; Majumdar SR
Diabetes Care; 2006 Nov; 29(11):2403-8. PubMed ID: 17065675
[TBL] [Abstract][Full Text] [Related]
13. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of hypoglycemia on healthcare in Spain.
Brito-Sanfiel M; Diago-Cabezudo J; Calderon A
Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
[TBL] [Abstract][Full Text] [Related]
16. [Impact of demographic changes on drug utilization related to diabetes in Aquitaine].
Taboulet F; Latry P; Fontaine S; Timmerman L
Cah Sociol Demogr Med; 1999; 39(2-3):253-69. PubMed ID: 10615566
[TBL] [Abstract][Full Text] [Related]
17. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
18. Intensive insulin therapy and insulin pumps.
Bode BW
Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
[TBL] [Abstract][Full Text] [Related]
19. [Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark].
Palmer AJ; Lammert M; Hermansen K
Ugeskr Laeger; 2008 Apr; 170(15):1250-4. PubMed ID: 18433583
[TBL] [Abstract][Full Text] [Related]
20. Insulin pump therapy in childhood diabetes-cost implications for Primary Care Trusts.
Feltbower RG; Campbell FM; Bodansky HJ; Stephenson CR; McKinney PA
Diabet Med; 2006 Jan; 23(1):86-9. PubMed ID: 16409571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
